A 42-year-old male with a history of end-stage heart failure secondary to idiopathic cardiomyopathy diagnosed in 1998, with severely dilated left ventricle, was treated with enalapriloc, 20% end-stage, hydrochlorothiazide and hydrochlorothiazide.